Accendra Health, Inc
Price
FilingsNewest: 8-K/A, Director or officer changeSep 28 →InsidersNo open-market buys or sales.→HoldersColiseum 17.0%BlackRock 7.2%Bank OF America Corp /de/ 4.9%→Financing →PeersClosest companies: VMD, ACHC, NUTX→
From the filings
Figures
- Revenue
- $2.65Blast 12 months
- Net income
- −$302.1Mlast 12 months
- Operating cash flow
- −$116.8Mlast 12 months
- Cash and equivalents
- $7.7Mat the last balance sheet
- Total debt
- $1.72Bat the last balance sheet
- Shares outstanding
- 76.9M shareson issue